Page last updated: 2024-08-18

pyrroles and Spinal Neoplasms

pyrroles has been researched along with Spinal Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adeduntan, R; Antoni, D; Noël, G; Paix, A; Waissi, W1
Jafri, M; Porfiri, E1
Bozas, G; Maraveyas, A; Ramasamy, V; Roy, A1
Barni, S; Cabiddu, M; Carpo, M; Ghilardi, M; Petrelli, F1
Haseke, N; Karl, A; Muacevic, A; Nuhn, P; Siebels, M; Staehler, M; Stief, CG; Tüllmann, C; Wowra, B1
Harada, S; Kitsukawa, S; Kozuka, T; Kudo, K; Miyazawa, K; Sukegawa, G; Yamamoto, S; Yonese, J; Yuasa, T1
Cardinal, E; Gallina, A; Karakiewicz, PI; Perrotte, P; Saad, F; Trinh, QD1

Reviews

1 review(s) available for pyrroles and Spinal Neoplasms

ArticleYear
Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2017, Volume: 21, Issue:1

    Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Female; Humans; Ilium; Indoles; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neoplasm Grading; Pyrroles; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Ribs; Spinal Cord Compression; Spinal Neoplasms; Spine; Sunitinib

2017

Other Studies

6 other study(ies) available for pyrroles and Spinal Neoplasms

ArticleYear
A differential response to sunitinib: sustained systemic response paralleled by intra-dural progression in the spine. Should standard response criteria be reviewed?
    Clinical genitourinary cancer, 2009, Volume: 7, Issue:2

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Indoles; Male; Middle Aged; Pyrroles; Spinal Neoplasms; Sunitinib; Tomography, X-Ray Computed

2009
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
    Onkologie, 2010, Volume: 33, Issue:6

    Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Synergism; Humans; Imidazoles; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Mandibular Diseases; Middle Aged; Neoplasm Staging; Osteonecrosis; Pyrroles; Sacrum; Spinal Neoplasms; Sunitinib; Zoledronic Acid

2010
Progression of intramedullary metastasis during perioperative cessation of sunitinib.
    Nature reviews. Urology, 2010, Volume: 7, Issue:11

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Indoles; Kidney Neoplasms; Middle Aged; Pyrroles; Spinal Neoplasms; Sunitinib

2010
Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.
    BJU international, 2011, Volume: 108, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Brain Neoplasms; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radiosurgery; Spinal Neoplasms; Sunitinib; Survival Analysis; Treatment Outcome; Young Adult

2011
Early onset recall pneumonitis during targeted therapy with sunitinib.
    BMC cancer, 2013, Jan-02, Volume: 13

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Glucocorticoids; Humans; Indoles; Kidney Neoplasms; Male; Molecular Targeted Therapy; Prednisolone; Protein Kinase Inhibitors; Pulse Therapy, Drug; Pyrroles; Radiation Dosage; Radiation Pneumonitis; Spinal Neoplasms; Sunitinib; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2013
Sunitinib relieves renal cell carcinoma spinal cord compression.
    European urology, 2007, Volume: 51, Issue:6

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Pyrroles; Spinal Cord Compression; Spinal Neoplasms; Sunitinib

2007